Agents and Actions Supplements

Airway Pathology of Functional Significance in Chronic Bronchitis and Chronic Obstructive Airway Disease.- 1) Airway Pathology of Functional Significance in Chronic Bronchitis and Chronic Obstructive Airway Disease.- Assessment of Long-Term Changes in Airway Function.- 2) Assessment of Long-Term Changes in Airway Function.- The Role of Measurements of Airway Responsiveness.- 3) The Role of Measurements of Airway Responsiveness.- Effects of Corticosteroids in "Chronic Bronchitis" and "Chronic Obstructive Airway Disease".- 4) Effects of Corticosteroids in "Chronic Bronchitis" and "Chronic Obstructive Airway Disease".- Epidemiology of Obstruction, Exacerbations and Hyper-Reactivity. Effects of Glucocorticosteroids and other Antiinflammatory Treatment.- 5) Epidemiology of Obstruction, Exacerbations and Hyper-Reactivity. Effects of Glucocorticosteroids and other Anti- Inflammatory Treatment.- Airways Hyperreactivity, Bronchial Inflammation and Obstructive Lung Disease.- 6) Airways Hyperreactivity, Bronchial Inflammation and Obstructive Lung Disease.- Clinical Trials in Asthma and Chronic Airflow Obstruction.- 7) Clinical Trials in Asthma and Chronic Airflow Obstruction.- A Critical Look at Blood Samples in CB and COAD.- 8) A Critical Look at Blood Samples in CB and COAD.- Seasonal Variation in The Phagocytic Activity and Arachidonic-Acid Metabolism of Human Blood Monocytes in Healthy Non-Smokers, Smokers and Chronic Bronchitics.- 9) Seasonal Variation in The Phagocytic Activity and Arachidonic-Acid Metabolism of Human Blood Monocytes in Healthy Non-Smokers, Smokers and Chronic Bronchitics.- A Critical View on Lavage Sampling Techniques.- 10) A Critical View on Lavage Sampling Techniques.- Assessment of Soluble Parameters in Sputum.- 11) Assessment of Soluble Parameters in Sputum.- Sputum Cell Counts in Airway Disease: a Useful Sampling Technique.- 12) Sputum Cell Counts in Airway Disease: a Useful Sampling Technique.- Bronchial Biopsies in Drug Intervention Studies in CB and COAD.- 13) Bronchial Biopsies in Drug Intervention Studies in CB and COAD.- Inflammatory Indices for Chronic Bronchitis and Chronic Obstructive Airway Disease. Cell Populations in Bronchial and Bronchoalveolar Lavage.- 14) Inflammatory Indices for Chronic Bronchitis and Chronic Obstructive Airway Disease. Cell Populations in Bronchial and Bronchoalveolar Lavage.- The Generation of Reactive Oxygen-Derived Species by Phagocytes.- 15) The Generation of Reactive Oxygen-Derived Species by Phagocytes.- Inflammatory Indices in Chronic Bronchitis. Monocyte-Macrophage Microbicidal Activity.- 16) Inflammatory Indices in Chronic Bronchitis. Monocyte-Macrophage Microbicidal Activity.- Indices of Inflammatory Activity in CB and COAD. Phagocyte Secretion and Chemotaxis.- 17) Indices of Inflammatory Activity in CB and COAD. Phagocyte Secretion and Chemotaxis.- Inflammatory Indices for Chronic Bronchitis and COAD Proteases and Antiproteases.- 18) Inflammatory Indices for Chronic Bronchitis and COAD Proteases and Antiproteases.- Exudative Indices in Airways Inflammation.- 19) Exudative Indices in Airways Inflammation.- The Measuring of "Respiratory-Membrane Permeability" and Local Production of Immunoglobulins and Antibodies by Means of an Analysis of Sputum.- 20) The Measuring of "Respiratory-Membrane Permeability" and Local Production of Immunoglobulins and Antibodies by Means of an Analysis of Sputum.- A Critical Look at Mucus Markers.- 21) A Critical Look at Mucus Markers.- Concluding Discussions.- Points of Importance in Long Term Intervention Studies in CB/COAD.- 22) Points of Importance in Long Term Intervention Studies in CB/COAD.- Which Markers of Inflammation Should be Used in Therapeutic Intervention Studies of CB/COAD?.- 23) Which Markers of Inflammation Should be Used in Therapeutic Intervention Studies of CB/COAD?.